| | | | | | | | | | | |
| POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | | | | | | | |
|
| | | UNI - EN REPORT No | 44 | / | 2023 |
| | |
| | | | | | | | | | | |
| Date of issue: | 2025-10-10 | | | | | | | | |
| | | | | | | | | |
| Short name of the issuer | | | | | | | |
| KRKA | |
| | | | | | | | | | |
| Subject | | | | | | | | | | |
| Acquisition of treasury shares | |
| | | | | | | | |
| Official market - legal basis | | | | | | |
| | |
| | | | | | | | | |
| Unofficial market - legal basis | | | | | |
| | |
| | | | | | | | | | | |
| Contents of the report: | | | | | | | | |
| With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 3 October 2025 up to and including 9 October 2025. Krka acquired 11,890 treasury shares in the total value of EUR 2,416,698 on the Ljubljana Stock Exchange as follows:
- on 3 October 2025: 2,272 shares at a VWAP of EUR 214.46,
- on 6 October 2025: 2,226 shares at a VWAP of EUR 210.73,
- on 7 October 2025: 2,316 shares at a VWAP of EUR 199.23,
- on 8 October 2025: 2,474 shares at a VWAP of EUR 197.63 and
- on 9 October 2025: 2,602 shares at a VWAP of EUR 196.00.
Price is calculated as volume weighted average price (VWAP).
Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.
The total number of treasury shares prior to these transactions was 2,337,825 representing 7.129% of all shares issued.
The total number of treasury shares after these transactions is 2,349,715 representing 7.165% of all shares issued.
The notice will be published on the Company's website (www.krka.biz) from 10 October 2025 onwards, for a minimum period of 5 years.
| |
| | | | | | | | | | |
| Annexes | | | | | | | | | | |
| File | Description | |
| Detailed report on acquisition of treasury shares.pdf | Detailed report on acquisition of treasury shares | |
| | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | KRKA, TOVARNA ZDRAVIL D.D. | | |
| | (fullname of the issuer) | | |
| | KRKA | | Farmaceutyczny (far) | | |
| | (short name of the issuer) | | (sector according to clasification
of the WSE in Warsow) | | |
| | 8501 | | Nove Mesto | | |
| | (post code) | | (city) | | |
| | Smarjeska | | 6 | | |
| | (street) | | (number) | | |
| | +386 7 331 21 11 | | +386 7 332 15 37 | | |
| | (phone number) | | | (fax) | | |
| | | | | | |
| | (e-mail) | | | (web site) | | |
| | nie dotyczy | | | | |
| | (NIP) | | | (REGON) | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | |
|
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |
| Date | Name | Position / Function | Signature | |
| 2025-10-10 | Jože Colarič | President of the Management Board and CEO | | |
| | | | | |